CellaVision AB (STU:C26)
€ 23.1 -0.65 (-2.74%) Market Cap: 559.99 Mil Enterprise Value: 558.02 Mil PE Ratio: 44.65 PB Ratio: 8.76 GF Score: 98/100

Q4 2021 CellaVision AB Earnings Call Transcript

Feb 04, 2022 / 10:00AM GMT
Release Date Price: €32.16 (+0.69%)
Operator

Hello, and welcome to the CellaVision Q4 2021 Report. Today, I am pleased to present the CEO, Simon Ãstergaard; and the CFO, Magnus Blixt. (Operator Instructions) Speakers, please begin.

Simon Ã;stergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much, and welcome, everybody, out there. So this is Simon Ãstergaard here, and I'm pleased to announce that we have Magnus Blixt, our CFO, with me in the room here.

Today, we are going to present our year-end bulletin in Q4 2021. And also, obviously, the full year consolidated results. So we will hop right into the financials for '21. And then we will actually jump into -- we're very excited to share our strategic direction for our 5-year plan. So that's the agenda for today.

If we go to the next slides after the financial, I can talk a little bit about the quarterly operational highlights. So essentially, we summarize our results as a strong finish to the year. We landed our revenues of SEK 164 million from Q4,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot